HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36,768	52,725	16,769	30,978	31,254	37,157
Short-Term Investments	615.11	16,212	11,298	12,350	24,690	17,858
Trading Asset Securities	-	10,629	50,793	88,661	84,017	103,019
Cash & Short-Term Investments	37,383	79,566	78,860	131,989	139,961	158,034
Cash Growth	-48.02%	0.90%	-40.25%	-5.70%	-11.44%	-10.08%
Accounts Receivable	14,658	18,120	11,464	13,072	11,648	17,599
Other Receivables	727.33	2,057	2,371	2,116	1,123	369.92
Receivables	19,397	20,188	14,646	16,202	14,157	19,349
Inventory	5,347	6,103	5,267	10,867	1,769	2,082
Prepaid Expenses	-	468.69	448.74	208.4	281.34	395.85
Other Current Assets	1,768	1,382	238.85	1,509	654.91	1,468
Total Current Assets	63,894	107,709	99,460	160,776	156,822	181,329
Property, Plant & Equipment	98,825	81,206	72,918	92,089	22,081	22,935
Long-Term Investments	211,300	254,694	146,038	44,749	24,346	38,850
Goodwill	-	-	1,772	21,925	-	1,896
Other Intangible Assets	58,566	44,780	54,029	69,506	62,809	75,440
Long-Term Accounts Receivable	-	-	-	341.17	363.96	571.04
Other Long-Term Assets	49,763	50,500	49,158	22,264	4,262	6,060
Total Assets	482,483	539,017	423,500	411,790	270,800	327,197
Accounts Payable	5,578	6,985	5,160	9,384	10,278	5,548
Accrued Expenses	1,559	2,029	2,240	697.15	717.82	584.35
Short-Term Debt	24,014	28,153	106,761	7,920	-	-
Current Portion of Long-Term Debt	26,124	12,276	7,060	387.2	-	-
Current Portion of Leases	318.97	632.14	922.33	2,145	668	377.78
Current Income Taxes Payable	-	52.6	7,555	132.13	-	19.36
Current Unearned Revenue	10.83	2.91	31.49	38.42	24.01	631.24
Other Current Liabilities	4,439	3,417	5,727	6,081	1,848	10,705
Total Current Liabilities	62,043	53,547	135,457	26,785	13,536	17,865
Long-Term Debt	98,069	82,529	51,410	136,189	3,500	10,734
Long-Term Leases	236.96	193.33	424.01	832.41	452.62	279.57
Long-Term Deferred Tax Liabilities	3,389	2,310	3,345	10,033	5,758	9,667
Other Long-Term Liabilities	3,853	1,045	1,036	1,201	224.73	250.38
Total Liabilities	168,235	140,192	192,288	175,724	24,188	39,453
Common Stock	61,432	61,416	51,407	48,831	48,223	24,009
Additional Paid-In Capital	320,197	319,343	168,141	222,910	240,895	294,133
Retained Earnings	-66,814	16,373	10,431	-40,963	-46,832	-60,188
Treasury Stock	-679.97	-679.97	-679.97	-	-	-
Comprehensive Income & Other	-248.99	1,889	1,499	3,947	3,904	29,227
Total Common Equity	313,887	398,340	230,797	234,725	246,189	287,181
Minority Interest	361.74	484.91	416.21	1,342	422.87	563.11
Shareholders' Equity	314,249	398,825	231,213	236,067	246,612	287,744
Total Liabilities & Equity	482,483	539,017	423,500	411,790	270,800	327,197
Total Debt	148,762	123,783	166,578	147,473	4,621	11,391
Net Cash (Debt)	-111,379	-44,217	-87,718	-15,484	135,340	146,642
Net Cash Growth	-	-	-	-	-7.71%	-10.46%
Net Cash Per Share	-937.08	-392.35	-861.84	-153.36	1362.33	1481.19
Filing Date Shares Outstanding	121.85	121.81	101.8	96.71	100.44	49.5
Total Common Shares Outstanding	121.85	121.81	101.8	101.71	100.44	99.01
Working Capital	1,851	54,162	-35,997	133,991	143,286	163,464
Book Value Per Share	2576.07	3270.06	2267.23	2307.67	2451.22	2900.59
Tangible Book Value	255,321	353,561	174,996	143,294	183,380	209,845
Tangible Book Value Per Share	2095.42	2902.45	1719.07	1408.78	1825.85	2119.48
Land	-	21,569	21,471	29,580	9,065	9,622
Buildings	-	23,221	23,221	19,950	4,547	5,511
Machinery	-	40,056	39,219	30,949	12,906	12,541
Construction In Progress	-	33,101	8,472	18,390	1,324	392.54

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.